Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer
Prostate is the most frequent cancer in men. Prostate cancer progression is driven by androgen steroid hormones, and delayed by androgen deprivation therapy (ADT). Androgens control transcription by stimulating androgen receptor (AR) activity, yet also control pre-mRNA splicing through less clear me...
Main Authors: | Jennifer Munkley, Ling Li, S R Gokul Krishnan, Gerald Hysenaj, Emma Scott, Caroline Dalgliesh, Htoo Zarni Oo, Teresa Mendes Maia, Kathleen Cheung, Ingrid Ehrmann, Karen E Livermore, Hanna Zielinska, Oliver Thompson, Bridget Knight, Paul McCullagh, John McGrath, Malcolm Crundwell, Lorna W Harries, Mads Daugaard, Simon Cockell, Nuno L Barbosa-Morais, Sebastian Oltean, David J Elliott |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/47678 |
Similar Items
-
Alterations in <it>LMTK2</it>, <it>MSMB </it>and <it>HNF1B </it>gene expression are associated with the development of prostate cancer
by: McCullagh Paul, et al.
Published: (2010-06-01) -
Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer
by: Zhuofan Mou, et al.
Published: (2022-08-01) -
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration
by: Jennifer Munkley, et al.
Published: (2017-07-01) -
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration
by: Munkley, J, et al.
Published: (2017) -
The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development
by: Thomas W Bebee, et al.
Published: (2015-09-01)